Task force on: 'Early markers of atherosclerosis: Influence of age and sex'

Journal of Cardiovascular Medicine

Volumn 14, Issue 10, 2013, Pages 757-766

  Ciccone, Marco Matteo ^a   Bilianou, Elene ^b   Balbarini, Alberto ^c   Gesualdo, Michele ^a   Ghiadoni, Lorenzo ^d   Metra, Marco ^e   Palmiero, Pasquale ^f   Pedrinelli, Roberto ^c   Salvetti, Massimo ^e   Scicchitano, Pietro ^a   Zito, Annapaola ^a   Novo, Salvatore ^g   Mattioli, Anna Vittoria ^h  

^a UNIVERSITY OF BARI   (Italy)

^b TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

^c Cardiothoracic and Vascular Department   (Italy)

^d UNIVERSITY OF PISA   (Italy)

^e UNIVERSITY OF BRESCIA   (Italy)

^f ASL BR 1   (Italy)

^g UNIVERSITY OF PALERMO   (Italy)

^h UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Antero posterior abdominal aorta diameter; Arterial stiffness; Carotid intima media thickness; Flow mediated vasodilatation; Left ventricular hypertrophy

Indexed keywords

ANKLE BRACHIAL INDEX; ANTERO POSTERIOR ABDOMINAL AORTA DIAMETER; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BRACHIAL ARTERY; CARDIOVASCULAR PARAMETERS; COMMON CAROTID ARTERY; ENDOTHELIUM; FLOW MEDIATED VASODILATATION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; RISK FACTOR; VASODILATATION;

AGE FACTORS; AORTA, ABDOMINAL; ATHEROSCLEROSIS; CAROTID INTIMA-MEDIA THICKNESS; DILATATION, PATHOLOGIC; DISEASE PROGRESSION; EARLY DIAGNOSIS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SEX FACTORS; TIME FACTORS; VASCULAR STIFFNESS; VASODILATION;

EID: 84885408178     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0b013e328362078d     Document Type: Article

References (103)

1. Jan M, Meng S, Chen NC, Mai J, Wang H, Yang XF. Inflammatory and autoimmune reactions in atherosclerosis and vaccine design informatics. J Biomed Biotechnol 2010; 2010:459798.
2. Ross R, Glomset JA. The pathogenesis of atherosclerosis (first of two parts). N Engl J Med 1976; 295:369-377.
3. Ross R, Glomset JA. The pathogenesis of atherosclerosis (second of two parts). N Engl J Med 1976; 295:420-425.
4. Ross R. The pathogenesis of atherosclerosis-an update. N Engl J Med 1986; 314:488-500.
5. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340:115-126.
6. Mangge H, Almer G, Truschnig-Wilders M, Schmidt A, Gasser R, Fuchs D. Inflammation, adiponectin, obesity and cardiovascular risk. Curr Med Chem 2010; 17:4511-4520.
7. Naya M, Morita K, Yoshinaga K, et al. Long-term smoking causes more advanced coronary endothelial dysfunction in middle-aged smokers compared to young smokers. Eur J Nucl Med Mol Imaging 2011; 38:491-498.
8. Juonala M, Magnussen CG, Venn A, et al. Influence of age on associations between childhood risk factors and carotid intima-media thickness in adulthood: The Cardiovascular Risk in Young Finns Study, the Childhood Determinants of Adult Health Study, the Bogalusa Heart Study, and the Muscatine Study for the International Childhood Cardiovascular Cohort (i3C) Consortium. Circulation 2010; 122:2514-2520.
9. Vaccarino V, Badimon L, Corti R, et al. Ischemic heart disease in women: Are there sex differences in pathophysiology and risk factors? Position paper from the Working Group on Coronary Pathophysiology & Microcirculation of the European Society of Cardiology. Cardiovasc Res 2011; 90:9-17.
10. Thijssen DH, Black MA, Pyke KE, et al. Assessment of flow mediated dilation (FMD) in humans: A methodological and technical guideline. Am J Physiol Heart Circ Physiol 2011; 300:H2-H12.
11. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39:257-265.
12. Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfield JE. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 1994; 24:471-476.
13. Tomiyama H, Matsumoto C, Yamada J, et al. The relationships of cardiovascular disease risk factors to flow-mediated dilatation in Japanese subjects free of cardiovascular disease. Hypertens Res 2008; 31:2019-2025.
14. Jensen-Urstad K, Johansson J. Gender difference in age-related changes in vascular function. J Intern Med 2001; 250:29-36.
15. Juonala M, Kähönen M, Laitinen T, et al. Effect of age and sex on carotid intima-media thickness, elasticity and brachial endothelial function in healthy adults: The cardiovascular risk in Young Finns Study. Eur Heart J 2008; 29:1198-1206.
16. Modena MG, Bonetti L, Coppi F, Bursi F, Rossi R. Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J Am Coll Cardiol 2002; 40:505-510.
17. Hu R, Wang WQ, Lau CP, Tse HF. Gender differences on brachial flow-mediated dilation and carotid intima-media thickness for prediction of spontaneous cardiovascular events. Clin Cardiol 2008; 31:525- 530.
18. Muiesan ML, Salvetti M, Paini A, et al. Prognostic role of flow-mediated dilatation of the brachial artery in hypertensive patients. J Hypertens 2008; 26:1612-1618.
19. Sherwood A, Bower JK, McFetridge-Durdle J, Blumenthal JA, Newby LK, Hinderliter AL. Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women. Arterioscler Thromb Vasc Biol 2007; 27:1782-1787.
20. Yavuz BB, Yavuz B, Sener DD, et al. Advanced age is associated with endothelial dysfunction in healthy elderly subjects. Gerontology 2008; 54:153-156.
21. Ryliskyte L, Ghiadoni L, Plantinga Y, et al. High-frequency ultrasonographic imaging of the endothelium-dependent flow-mediated dilatation (FMD) in a brachial artery: normative ranges in a group of low CV risk subjects of different ages. Proc West Pharmacol Soc 2004; 47:67- 68.
22. Ciccone MM, Miniello V, Marchioli R, et al. Morphological and functional vascular changes induced by childhood obesity. Eur J Cardiovasc Prev Rehabil 2011; 18:831-835.
23. Ghiadoni L, Donald AE, Cropley M, et al. Mental stress induces transient endothelial dysfunction in humans. Circulation 2000; 102:2473-2478.
24. Ghiadoni L, Magagna A, Versari D, et al. Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension 2003; 41:1281-1286.
25. Ciccone MM, Favale S, Scicchitano P, et al. Reversibility of the endothelial dysfunction after CPAP therapy in OSAS patients. Int J Cardiol 2012; 158:383-386.
26. Ciccone MM, Iacoviello M, Puzzovivo A, et al. Clinical correlates of endothelial function in chronic heart failure. Clin Res Cardiol 2011; 100:515-521.
27. Ciccone MM, Favale S, Bhuva A, et al. Anteroposterior diameter of the infrarenal abdominal aorta is higher in women with polycystic ovary syndrome. Vasc Health Risk Manag 2009; 5:561-566.
28. Allison MA, Kwan K, DiTomasso D, Wright CM, Criqui MH. The epidemiology of abdominal aortic diameter. J Vasc Surg 2008; 48:121- 127.
29. Norman P, Le M, Pearce C, Jamrozik K. Infrarenal aortic diameter predicts all-cause mortality. Arterioscler Thromb Vasc Biol 2004; 24:1278-1282.
30. Patel AS, MacKey RH, Wildman RP, et al. Cardiovascular risk factors associated with enlarged diameter of the abdominal aortic and iliac arteries in healthy women. Atherosclerosis 2005; 178:311-317.
31. Forsdahl SH, Solberg S, Singh K, Jacobsen BK. Abdominal aortic aneurysms, or a relatively large diameter of nonaneurysmal aortas, increase total and cardiovascular mortality: The Tromsø study. Int J Epidemiol 2010; 39:225-232.
32. Sonesson B, Ahlgren AR, Lazer L, Länne T. Does long-term smoking affect aortic stiffness more in women than in men? Clin Physiol 1997; 17:439-447.
33. Rajkumar C, Bonapace S, Starr J, Radia M, Bulpitt CJ. Association between abdominal aortic diameter and peripheral vascular disease. J Hum Hypertens 1997; 11:589-591.
34. Solberg S, Forsdahl SH, Singh K, Jacobsen BK. Diameter of the infrarenal aorta as a risk factor for abdominal aortic aneurysm: The Tromsø Study, 1994-2001. Eur J Vasc Endovasc Surg 2010; 39:280-284.
35. Long A, Bui HT, Barbe C, et al. Prevalence of abdominal aortic aneurysm and large infrarenal aorta in patients with acute coronary syndrome and proven coronary stenosis: A prospective monocenter study. Ann Vasc Surg 2010; 24:602-608.
36. Grimshaw GM, Thompson JM. Changes in diameter of the abdominal aorta with age: An epidemiological study. J Clin Ultrasound 1997; 25:7- 13.
37. Palombo D, Lucertini G, Pane B, Mazzei R, Spinella G, Brasesco PC. District-based abdominal aortic aneurysm screening in population aged 65 years and older. J Cardiovasc Surg (Torino) 2010; 51:777-782.
38. Wilmink AB, Pleumeekers HJ, Hoes AW, Hubbard CS, Grobbee DE, Quick CR. The infrarenal aortic diameter in relation to age: only part of the population in older age groups shows an increase. Eur J Vasc Endovasc Surg 1998; 16:431-437.
39. Sawabe M, Hamamatsu A, Chida K, Naka Mieno M, Ozawa T. Age is a major pathobiological determinant of aortic dilatation: A large autopsy study of community deaths. J Atheroscler Thromb 2011; 18:157- 165.
40. Pannacciulli N, De Pergola G, Ciccone M, Rizzon P, Giorgino F, Giorgino R. Effect of family history of type 2 diabetes on the intima-media thickness of the common carotid artery in normal-weight, overweight, and obese glucose-tolerant young adults. Diabetes Care 2003; 26:1230-1234.
41. Touboul PJ, Hennerici MG, Meairs S, et al. Mannheim carotid intimamedia thickness consensus (2004-2006). Cerebrovasc Dis 2007; 23:75-80.
42. Ciccone MM, Balbarini A, Porcelli MT, et al. Carotid artery intima-media thickness: normal and percentile values in the Italian population (CAMP study). Eur J Cardiovasc Prev Rehabil 2011; 18:650-655.
43. De PergolaG, Ciccone M, Pannacciulli N, et al. Lower insulin sensitivity as an independent risk factor for carotid wall thickening in normotensive, nondiabetic, nonsmoking normal weight and obese premenopausal women. Int J Obes Relat Metab Disord 2000; 24:825-829.
44. Ciccone M, Vettor R, Pannacciulli N, et al. Plasma leptin is independently associated with the intima-media thickness of the common carotid artery. Int J Obes Relat Metab Disord 2001; 25:805-810.
45. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: A direct measurement with ultrasound imaging. Circulation 1986; 74:1399-1406.
46. Roman MJ, Naqvi TZ, Gardin JM, et al. Clinical application of noninvasive vascular ultrasound in cardiovascular risk stratification: A report from the American Society of Echocardiography and the Society of Vascular Medicine and Biology. J Am Soc Echocardiogr 2006; 19:943-954.
47. Novo S, Visconti CL, Amoroso GR, et al. Asymptomatic carotid lesions add to cardiovascular risk prediction. Eur J Cardiovasc Prev Rehabil 2010; 17:514-518.
48. Novo S, Carita P, Corrado E, et al. Preclinical carotid atherosclerosis enhances the global cardiovascular risk and increases the rate of cerebroand cardiovascular events in a five-year follow-up. Atherosclerosis 2010; 211:287-290.
49. Böhm B, Hartmann K, Buck M, Oberhoffer R. Sex differences of carotid intima-media thickness in healthy children and adolescents. Atherosclerosis 2009; 206:458-463.
50. Jain A, McClelland RL, Polak JF, et al. Cardiovascular imaging for assessing cardiovascular risk in asymptomatic men versus women: The Multi-Ethnic Study of Atherosclerosis (MESA). Circ Cardiovasc Imaging 2011; 4:8-15.
51. Johnsen SH, Mathiesen EB, Joakimsen O, et al. Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men: A 6-year follow-up study of 6226 persons: The Tromso Study. Stroke 2007; 38:2873-2880.
52. Muscelli E, Kozakova M, Flyvbjerg A, et al. The effect of menopause on carotid artery remodeling, insulin sensitivity, and plasma adiponectin in healthy women. Am J Hypertens 2009; 22:364-370.
53. Ciccone MM, De Pergola G, Porcelli MT, et al. Increased carotid IMT in overweight and obese women affected by Hashimoto's thyroiditis: An adiposity and autoimmune linkage? BMC Cardiovasc Disord 2010; 10:22.
54. de Sousa G, Brodoswki C, Kleber M, Wunsch R, Reinehr T. Association between androgens, intima-media thickness and the metabolic syndrome in obese adolescent girls. Clin Endocrinol (Oxf) 2010; 72:770-774.
55. Woodard GA, Brooks MM, Barinas-Mitchell E, MacKey RH, Matthews KA, Sutton-Tyrrell K. Lipids, menopause, and early atherosclerosis in Study of Women's Health Across the Nation Heart women. Menopause 2011; 18:376-384.
56. De Pergola G, Pannacciulli N, Ciccone M, Tartagni M, Rizzon P, Giorgino R. Free testosterone plasma levels are negatively associated with the intima-media thickness of the common carotid artery in overweight and obese glucose-tolerant young adult men. Int J Obes Relat Metab Disord 2003; 27:803-807.
57. Barra S, Gaeta G, Cuomo S, et al. Early increase of carotid intima-media thickness in children with parental history of premature myocardial infarction. Heart 2009; 95:642-645.
58. Juonala M, Viikari JS, Kähönen M, et al. Life-time risk factors and progression of carotid atherosclerosis in young adults: The Cardiovascular Risk in Young Finns study. Eur Heart J 2010; 31:1745-1751.
59. Ygando Y, Yamamoto K, Kawano H, et al. Attenuated age-related carotid arterial remodeling in adults with a high level of cardiorespiratory fitness. J Atheroscler Thromb 2011; 18:248-254.
60. Takato T, Yamada N, Ashida T. Effects of aging and sex on progression of carotid intima-media thickness: A retrospective 6-year follow-up study. Geriatr Gerontol Int 2008; 8:172-179.
61. Morrison KM, Dyal L, Conner W, et al. Cardiovascular risk factors and noninvasive assessment of subclinical atherosclerosis in youth. Atherosclerosis 2010; 208:501-505.
62. Tendera M, Aboyans V, Bartelink ML, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 2011; 32:2851-2906.
63. Fowkes FG, Murray GD, Butcher I, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: A meta-analysis. JAMA 2008; 300:197-208.
64. Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A, Grobbee DE. Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol 1998; 18:185-192.
65. Newman AB. Peripheral arterial disease: insights from population studies of older adults. J Am Geriatr Soc 2000; 48:1157-1162.
66. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992; 326:381- 386.
67. Murabito JM, Evans JC, Larson MG, Nieto K, Levy D, Wilson PWF. The ankle-brachial index in the elderly and risk of stroke, coronary disease, and death. The Framingham Study. Arch Intern Med 2003; 163:1939- 1942.
68. Newman AB, Sutton-Tyrrell K, Vogt MT, Kuller LH. Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. JAMA 1993; 270:487-489.
69. McDermott MM, Ferrucci L, Liu K, et al. Women with peripheral arterial disease experience faster functional decline than men with peripheral arterial disease. J Am Coll Cardiol 2011; 57:707-714.
70. Baena-Diez JM, Alzamora MT, Foreś R, Pera G, Toran P, Sorribesf M. Ankle-brachial index improves the classification of cardiovascular risk: PERART/ARTPER Study. Rev Esp Cardiol 2011; 64:186-192.
71. Sigvant B, Wiberg-Hedman K, Bergqvist D, et al. A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences. J Vasc Surg 2007; 45:1185- 1191.
72. Sadrzadeh Rafie AH, Stefanick ML, Sims ST, et al. Sex differences in the prevalence of peripheral artery disease in patients undergoing coronary catheterization. Vasc Med 2010; 15:443-450.
73. Tsai PC, Lin TH, Hsu PC, Wang YS, Lio YC, Juo SHH. Polymorphism of 270AG in BRAP is associated with lower ankle-brachial index in a Taiwanese population. J Atheroscler Thromb 2011; 18:413-420.
74. Muiesan ML, Pasini G, Salvetti M, et al. Cardiac and vascular structural changes prevalence and relation to ambulatory blood pressure in a middle-aged general population in Northern Italy: The Vobarno Study. Hypertension 1996; 27:1046-1052.
75. Kohara K, Zhao B, Jiang Y, et al. Relation of left ventricular hypertrophy and geometry to asymptomatic cerebrovascular damage in essential hypertension. Am J Cardiol 1999; 83:367-370.
76. Małek LA, Spiewak M, Kłopotowski M, et al. Influence of left ventricular hypertrophy on infarct size and left ventricular ejection fraction in STelevation myocardial infarction. Eur J Radiol 2012; 81:e177-e181.
77. Ang DS, Pringle SD, Struthers AD. The cardiovascular risk factor, left ventricular hypertrophy, is highly prevalent in stable, treated angina pectoris. Am J Hypertens 2007; 20:1029-1035.
78. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18:1440-1463.
79. Chien KL, Sung FC, Hsu HC, Su TC, Lee YT. Left ventricular mass and correlated atherosclerotic risk factors in young adolescents: report from Chin-Shan community cardiovascular study in Taiwan. Atherosclerosis 2001; 155:431-437.
80. de Simone G, Daniels SR, Kimball TR, et al. Evaluation of concentric left ventricular geometry in humans: evidence for age-related systematic underestimation hypertension. Hypertension 2005; 45:64-68.
81. Muiesan ML, Salvetti M, Monteduro C, et al. Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients. Hypertension 2004; 43:731-738.
82. Gupta S, Berry JD, Ayers CR, et al. Left ventricular hypertrophy, aortic wall thickness, and lifetime predicted risk of cardiovascular disease: The Dallas Heart Study. JACC Cardiovasc Imaging 2010; 3:605-613.
83. Rosen BD, Fernandes VR, Nasir K, et al. Age, increased left ventricular mass, and lower regional myocardial perfusion are related to greater extent of myocardial dyssynchrony in asymptomatic individuals: The multiethnic study of atherosclerosis. Circulation 2009; 120:859- 866.
84. Mattace-Raso F, van Popele NM, Schalekamp MA, van der Cammen TJ. Intima-media thickness of the common carotid arteries is related to coronary atherosclerosis and left ventricular hypertrophy in older adults. Angiology 2002; 53:569-574.
85. Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen JC, Castelli WP. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study. Ann Intern Med 1988; 108:7-13.
86. De Simone G, Devereux RB, Daniels SR, Meyer RA. Gender differences in left ventricular growth. Hypertension 1995; 26:979-983.
87. De Simone G, Devereux RB, Chinali M, et al. Sex differences in obesityrelated changes in left ventricular morphology: The Strong Heart Study. J Hypertens 2011; 29:1431-1438.
88. Gerdts E, Okin PM, de Simone G, et al. Gender differences in left ventricular structure and function during antihypertensive treatment: The Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 2008; 51:1109-1114.
89. Liao Y, Cooper RS, Mensah GA, Cooper RS, McGee DL. Left ventricular hypertrophy has a greater impact on survival in women than in men. Circulation 1995; 92:805-810.
90. Berenson GS, Wattigney WA, Tracy RE, et al. Atherosclerosis of the aorta and coronary arteries and cardiovascular risk factors in persons aged 6 to 30 years and studied at necropsy (The Bogalusa Heart Study). Am J Cardiol 1992; 70:851-858.
91. Agabiti-Rosei E, Mancia G, O'Rourke MF, et al. Central blood pressure measurements and antihypertensive therapy: A consensus document. Hypertension 2007; 50:154-160.
92. Williams B, Lacy PS, Thom SM, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113:1213-1225.
93. Vlachopoulos C, Aznaouridis K, O'Rourke MF, Safar ME, Baou K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: A systematic review and meta-analysis. Eur Heart J 2010; 31:1865-1871.
94. Boutouyrie P, Achouba A, Trunet P, et al. Amlodipine-valsartan combination decreases central systolic blood pressure more effectively than the amlodipine-atenolol combination: The EXPLOR study. Hypertension 2010; 55:1314-1322.
95. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: A systematic review and meta-analysis. J Am Coll Cardiol 2010; 55:1318-1327.
96. Vermeersch SJ, Rietzschel ER, De Buyzere ML, et al.Ageandgender related patterns in carotid-femoral PWV and carotid and femoral stiffness in a large healthy, middle-aged population. J Hypertens 2008; 26:1411-1419.
97. Paini A, Boutouyrie P, Calvet D, Tropeano AI, Laloux B, Laurent S. Carotid and aortic stiffness: determinants of discrepancies. Hypertension 2006; 47:371-376.
98. McEniery CM, Yasmin A, Hall IR, et al. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: The Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol 2005; 46:1753-1760.
99. Plantinga Y, Ghiadoni L, Magagna A, et al. Peripheral wave reflection and endothelial function in untreated essential hypertensive patients with and without the metabolic syndrome. J Hypertens 2008; 26:1216-1222.
100. Protogerou AD, Blacher J, Aslangul E, et al. Gender influence on metabolic syndrome's effects on arterial stiffness and pressure wave reflections in treated hypertensive subjects. Atherosclerosis 2007; 193:151-158.
101. Cecelja M, Chowienczyk P. Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: A systematic review. Hypertension 2009; 54:1328-1336.
102. Reference Values for Arterial Stiffness Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'. Eur Heart J 2010; 31:2338-2350.
103. Muiesan ML, Salvetti M, Paini A, et al. Pulse wave velocity and cardiovascular risk stratification in a general population: The Vobarno study. J Hypertens 2010; 28:1935-1943.